Vincerx Pharma (VINC) announced its intention to file a Form 25 Notification of Delisting with the SEC on or about April 28, which will remove ...

Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Ironwood Pharma (IRWD – Research Report) today. The company’s shares closed last Friday at $0.95. Discover outperforming ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

Tariffs on pharmaceuticals would go against a duty-free agreement that the U.S. signed on to under the World Trade Organization, which barely held up during Trump’s first term. Under the 1994 ...

Following the recently granted patent in India for a prolonged-release pharmaceutical formulation using liposomes to encapsulate CBD, Innocan is actively advancing its efforts to strengthen ...

A Russian missile struck a warehouse belonging to Kusum Healthcare, an Indian pharmaceutical company, in Ukraine, prompting condemnation from the Ukrainian embassy, which alleged a deliberate ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs he has already imposed on most goods entering the United States ...

Given the extent of India’s pharma exports to US, this has created a certain bit of uncertainty in the market. Trump said the US would impose tariffs on autos, pharmaceuticals and aluminum in ...

BERLIN, April 10, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.

Global drugmakers’ stocks dropped across the board today after U.S. President Donald Trump reiterated plans for a “major” tariff on pharmaceutical imports, threatening an interwoven supply ...